Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kersten

Showing results (141-150 of 166) with videos related to

Pageof 17
Sort By:
Hemasphere|August 18, 2020
Consensus Statement on the Management of Waldenström Macroglobulinemia Patients During the COVID-19 PandemicDipti Talaulikar, Ranjana H Advani, Andrew R Branagan, et al.
Bone Marrow Transplantation|June 6, 2017
A phase I/II minor histocompatibility antigen-loaded dendritic cell vaccination trial to safely improve the efficacy of donor lymphocyte infusions in myelomaL E Franssen, M W H Roeven, W Hobo, et al.
Leukemia|September 5, 2015
The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cellsR Thijssen, J Ter Burg, G G W van Bochove, et al.
Leukemia|September 8, 2016
The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cellsR Thijssen, J Ter Burg, G G W van Bochove, et al.
The Journal of Investigative Dermatology|February 22, 2023
CYSRT1: An Antimicrobial Epidermal Protein that Can Interact with Late Cornified Envelope ProteinsHanna Niehues, Gijs Rikken, Ferry F J Kersten, et al.
European Journal of Heart Failure|August 30, 2024
Rationale and design of RESILIENCE: A prospective randomized clinical trial evaluating remote ischaemic conditioning for the prevention of anthracycline cardiotoxicityAndrea Moreno-Arciniegas, Alberto García, Malte Kelm, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 5, 2024
Human immunodeficiency virus-associated lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upK Hübel, M Bower, I Aurer, et al.
Hemasphere|September 5, 2024
Human immunodeficiency virus-associated Lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upKai Hübel, Mark Bower, Igor Aurer, et al.
Annals of Hematology|December 7, 2017
Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimensL E M Oosten, M E D Chamuleau, F W Thielen, et al.
American Journal of Hematology|March 3, 2023
Bendamustine plus rituximab for the treatment of Waldenström Macroglobulinemia: Patient outcomes and impact of bendamustine dosingSuzanne O Arulogun, Duncan Brian, Harshita Goradia, et al.
Pageof 17

Showing results (141-150 of 166) with videos related to

Sort By:
Pageof 17
Hemasphere|August 18, 2020
Consensus Statement on the Management of Waldenström Macroglobulinemia Patients During the COVID-19 PandemicDipti Talaulikar, Ranjana H Advani, Andrew R Branagan, et al.
Bone Marrow Transplantation|June 6, 2017
A phase I/II minor histocompatibility antigen-loaded dendritic cell vaccination trial to safely improve the efficacy of donor lymphocyte infusions in myelomaL E Franssen, M W H Roeven, W Hobo, et al.
Leukemia|September 5, 2015
The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cellsR Thijssen, J Ter Burg, G G W van Bochove, et al.
Leukemia|September 8, 2016
The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cellsR Thijssen, J Ter Burg, G G W van Bochove, et al.
The Journal of Investigative Dermatology|February 22, 2023
CYSRT1: An Antimicrobial Epidermal Protein that Can Interact with Late Cornified Envelope ProteinsHanna Niehues, Gijs Rikken, Ferry F J Kersten, et al.
European Journal of Heart Failure|August 30, 2024
Rationale and design of RESILIENCE: A prospective randomized clinical trial evaluating remote ischaemic conditioning for the prevention of anthracycline cardiotoxicityAndrea Moreno-Arciniegas, Alberto García, Malte Kelm, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 5, 2024
Human immunodeficiency virus-associated lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upK Hübel, M Bower, I Aurer, et al.
Hemasphere|September 5, 2024
Human immunodeficiency virus-associated Lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upKai Hübel, Mark Bower, Igor Aurer, et al.
Annals of Hematology|December 7, 2017
Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimensL E M Oosten, M E D Chamuleau, F W Thielen, et al.
American Journal of Hematology|March 3, 2023
Bendamustine plus rituximab for the treatment of Waldenström Macroglobulinemia: Patient outcomes and impact of bendamustine dosingSuzanne O Arulogun, Duncan Brian, Harshita Goradia, et al.
Pageof 17